Immutep Completes A$6.31 Million Share Purchase Plan; Raises Total of A$13.16 Million

NEXT STORY
Liver Biopsy Data from POISE Phase 3 Substudy Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
PREV STORY
Update: Konica Minolta Healthcare, HydroCision Announce Distribution Agreement for TenJet System Used in Minimally Invasive Tendinopathy Treatments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

BeiGene Announces Clinical Results of Zanubrutinib in Mantle Cell Lymphoma From Two Presentations at the 60th American Society of Hematology Annual Meeting

Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm ...

author_avatar
NASDAQ Market News

In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027, Growing at a CAGR of 7% From 2020 with COVID-19 Impact- Meticulous Research® Analysis

author_avatar
NASDAQ Market News